Human MIF/GIF/GLIF ORF/cDNA clone-Lentivirus particle (NM_002415.1)
Cat. No.: vGMLP001966
Pre-made Human MIF/GIF/GLIF Lentiviral expression plasmid for MIF lentivirus packaging, MIF lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
MIF/GIF products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
| Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
|---|---|---|---|
| vGMLP001966 | Human MIF Lentivirus particle | Pilot Grade | 1.0E+8TU |
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| Research Grade | 1.0E+8TU | ||
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMLP001966 |
| Gene Name | MIF |
| Accession Number | NM_002415.1 |
| Gene ID | 4282 |
| Species | Human |
| Product Type | Lentivirus particle (overexpression) |
| Insert Length | 348 bp |
| Gene Alias | GIF,GLIF,MMIF |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGCCGATGTTCATCGTAAACACCAACGTGCCCCGCGCCTCCGTGCCGGACGGGTTCCTCTCCGAGCTCACCCAGCAGCTGGCGCAGGCCACCGGCAAGCCCCCCCAGTACATCGCGGTGCACGTGGTCCCGGACCAGCTCATGGCCTTCGGCGGCTCCAGCGAGCCGTGCGCGCTCTGCAGCCTGCACAGCATCGGCAAGATCGGCGGCGCGCAGAACCGCTCCTACAGCAAGCTGCTGTGCGGCCTGCTGGCCGAGCGCCTGCGCATCAGCCCGGACAGGGTCTACATCAACTATTACGACATGAACGCGGCCAATGTGGGCTGGAACAACTCCACCTTCGCCTAA |
| ORF Protein Sequence | MPMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Biosimilar | GMP-Bios-ab-265 | Pre-Made Imalumab biosimilar, Whole mAb, Anti-MIF Antibody: Anti-GIF/GLIF/MMIF therapeutic antibody |
| Target Antibody | GM-Tg-g-T39977-Ab | Anti-MIF/ GIF/ GLIF monoclonal antibody |
| Target Antigen | GM-Tg-g-T39977-Ag | MIF VLP (virus-like particle) |
| ORF Viral Vector | pGMLP001966 | Human MIF Lentivirus plasmid |
| ORF Viral Vector | pGMAD001167 | Human MIF Adenovirus plasmid |
| ORF Viral Vector | vGMLP001966 | Human MIF Lentivirus particle |
| ORF Viral Vector | vGMAD001167 | Human MIF Adenovirus particle |
Target information
| Target ID | GM-T39977 |
| Target Name | MIF |
|
Gene Group Identifier (Target Gene ID in Homo species) |
4282 |
| Gene ID |
100053618 (Equus caballus), 101090298 (Felis catus), 17319 (Mus musculus), 280858 (Bos taurus) 4282 (Homo sapiens), 574298 (Macaca mulatta), 595146 (Canis lupus familiaris), 81683 (Rattus norvegicus) |
| Gene Symbols & Synonyms | MIF,Mif,MMIF,GIF,DER6,Glif,GLIF |
| Target Alternative Names | DER6,GIF,GLIF,Glif,Glycosylation-inhibiting factor (GIF),L-dopachrome isomerase,L-dopachrome tautomerase,MIF,MMIF,Macrophage migration inhibitory factor,Mif,Phenylpyruvate tautomerase |
| Uniprot Accession |
P14174,P30904,P34884,P80177,Q6DN04
Additional SwissProt Accessions: P34884,P80177,P14174,Q6DN04,P30904 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target, Immuno-oncology Target, INN Index |
| Disease | cancer, Ovary Cancer, Kidney transplant rejection, Congenital occlusion of ureteropelvic junction, Sepsis |
| Disease from KEGG | Metabolic pathways |
| Gene Ensembl | ENSMUSG00000033307, ENSBTAG00000007375, ENSG00000240972, ENSMMUG00000009106, ENSCAFG00845024852 |
| Target Classification | Checkpoint-Immuno Oncology |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


